FDA Issues Communication Regarding a Possible Link Between Breast Implants and Anaplastic Large Cell Lymphoma (ALCL)
The FDA has issued a statement alerting physicians and patients to a possible link between breast implants and a rare type of cancer. Although ALCL is extremely rare, the FDA believes that women with breast implants may have a very small but increased risk of developing the condition. ALCL in the presence of breast implants has […]
- Posted on: Jan 26 2011